{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-22-191340","form_type":"8-K","ticker":"FULC","cik":"0001680581","company_name":"Fulcrum Therapeutics, Inc.","filed_at":"2022-07-11T23:59:59+00:00","discovered_at":"2026-05-14T18:03:56.639119+00:00","generated_at":"2026-06-24T17:33:21.038815+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Chief Medical Officer Chris Morabito resigns effective July 13, 2022","bullets":["Chris Morabito, M.D., stepped down as Chief Medical Officer of Fulcrum Therapeutics.","Resignation effective July 13, 2022; he left to pursue another opportunity.","No replacement announced; departure not due to any disagreement with company.","Morabito's resignation follows no known operational or financial disputes.","Fulcrum did not provide details on interim CMO or search timeline."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-22-191340","json":"https://secwatch.observer/filing/0001193125-22-191340.json","markdown":"https://secwatch.observer/filing/0001193125-22-191340.md","text":"https://secwatch.observer/filing/0001193125-22-191340.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1680581/000119312522191340/0001193125-22-191340-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1680581/000119312522191340/d338706d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-24T17:33:21.038815+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"bdf645abed","claim":"Chris Morabito, M.D. resigned as Chief Medical Officer at Fulcrum Therapeutics, Inc..","evidence_excerpt":"On July 8, 2022, Chris Morabito, M.D., Chief Medical Officer of Fulcrum Therapeutics, Inc., or Fulcrum, notified Fulcrum of his resignation from this position and from his employment with Fulcrum, to be effective on July 13, 2022, in order to pursue a new opportunity.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1680581/000119312522191340/0001193125-22-191340-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Chief Medical Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}